Long - cytk on expansion breakout

Cytokintics looks great for a follow through on expansion breakout made a 2 month new high on surging volume due to being listed on the s&p smallcap 600 with last closing day being the largest in its range of the last 7-9 trading days. Buy stop in just above the breakout high with 1day expiry.

This stock is also undervalued, leading its peers with good fundamentals in recent headlines.

Trade closed: target reached:

hit and run job before earnings